Results for “”

Entry Author Date Location
UiPath Snags $225M To Expand Robotic Workforce for Businesses 09/18/18 San Francisco
The Rise of Robocalls and Cell Scams—and How to Stop Them 09/14/18 National
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Acorda’s Tough Week Continues as FDA Delays Parkinson’s Drug Review 09/13/18 New York
Living on the Edge: Amazon, AT&T, Packet Pursue “Cloudlet” Computing 09/12/18 San Francisco
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care 09/12/18 New York
PepsiCo Expands Nutrition Greenhouse Startup Program to U.S. 09/10/18 New York
FDA, Following EMA, Nixes Amicus’ Plans for Speedy OK of Pompe Drug 09/10/18 New York
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away 09/07/18 National
After a High-Speed Decade, Agios CEO David Schenkein to Step Aside 09/04/18 Boston
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More 08/31/18 National
Wireless Internet Firms Take On Big Telecoms in Cities and Suburbs 08/31/18 San Francisco
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug 08/30/18 Boston
Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA 08/27/18 New York
Eyeing Approval, Pfizer Touts Tafamidis Study, but Details Lacking 08/27/18 New York
Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More 08/24/18 National
Google, Dell EMC, Esther Dyson Join XCON 2018 Lineup 08/23/18 Boston
After Launching Women’s Mentor Network, Lisa Suennen Sets Sail from GE 08/22/18 San Francisco
Exact Sciences Shares Rise After Company Unveils Pfizer Partnership 08/22/18 Wisconsin
Facebook, NYU Pin Hope of Faster MRIs on Artificial Intelligence 08/21/18 San Francisco
Would Uber’s IPO Be a Revival or a Reckoning? 08/17/18 Boston
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer 08/17/18 New York
Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More 08/17/18 National
DoorDash Valued at $4 Billion After Adding $250M in New Funding 08/16/18 San Francisco
Pain Drug Race Continues as Regeneron Posts Early Phase 3 Results 08/16/18 New York
With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines 08/16/18 New York
Tech Hiring Surges in Bay Area, NY, Boston: See Q2’s Top Employers 08/16/18 Boston
Fidelity Vets Launch Castle Island Ventures, a $30M Blockchain Fund 08/15/18 Boston
New Biotech Magnolia Neurosciences Gets $31M For Neuroprotective Drugs 08/13/18 New York
Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals 08/10/18 New York
Page 1 of 75 next page »